Igene Biotechnology, Inc. (IGNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2009 | -1.06 Million USD | 51.11% |
| 2008 | -2.18 Million USD | -1019.68% |
| 2007 | 237.94 Thousand USD | 157.13% |
| 2006 | -416.51 Thousand USD | 0.0% |
| 2003 | -624.74 Thousand USD | 66.25% |
| 2002 | -1.85 Million USD | -12.99% |
| 2001 | -1.63 Million USD | -8.51% |
| 2000 | -1.5 Million USD | 17.92% |
| 1999 | -1.83 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2010 Q1 | -540.88 Thousand USD | -57.61% |
| 2010 Q2 | -822.06 Thousand USD | -51.99% |
| 2010 Q3 | -625.5 Thousand USD | 23.91% |
| 2009 Q2 | -593.77 Thousand USD | -108.98% |
| 2009 FY | -1.06 Million USD | 51.11% |
| 2009 Q4 | -343.17 Thousand USD | -326.95% |
| 2009 Q1 | -284.13 Thousand USD | 76.65% |
| 2009 Q3 | 151.21 Thousand USD | 125.47% |
| 2008 Q1 | -321.42 Thousand USD | -517.76% |
| 2008 Q4 | -1.21 Million USD | -395.71% |
| 2008 Q3 | -245.44 Thousand USD | 39.36% |
| 2008 Q2 | -404.74 Thousand USD | -25.92% |
| 2008 FY | -2.18 Million USD | -1019.68% |
| 2007 Q1 | 47.08 Thousand USD | 126.33% |
| 2007 Q2 | 157.36 Thousand USD | 234.23% |
| 2007 FY | 237.94 Thousand USD | 157.13% |
| 2007 Q4 | 76.93 Thousand USD | 277.12% |
| 2007 Q3 | -43.43 Thousand USD | -127.6% |
| 2006 FY | -416.51 Thousand USD | 0.0% |
| 2006 Q4 | -178.77 Thousand USD | -577.83% |
| 2006 Q3 | -26.37 Thousand USD | -148.1% |
| 2006 Q2 | 54.83 Thousand USD | 120.6% |
| 2006 Q1 | -266.2 Thousand USD | 0.0% |
| 2005 Q3 | 44.43 Thousand USD | 0.0% |
| 2004 Q1 | -56.34 Thousand USD | -16.14% |
| 2004 Q2 | -215.08 Thousand USD | -281.72% |
| 2004 Q3 | -6197.00 USD | 97.12% |
| 2003 Q2 | -10.83 Thousand USD | 97.21% |
| 2003 FY | -624.74 Thousand USD | 66.25% |
| 2003 Q1 | -388.37 Thousand USD | -270.19% |
| 2003 Q3 | -176.56 Thousand USD | -1529.27% |
| 2003 Q4 | -48.51 Thousand USD | 72.52% |
| 2002 Q2 | -498.95 Thousand USD | -0.17% |
| 2002 FY | -1.85 Million USD | -12.99% |
| 2002 Q1 | -498.09 Thousand USD | -79.3% |
| 2002 Q4 | -104.91 Thousand USD | 88.71% |
| 2002 Q3 | -928.98 Thousand USD | -86.19% |
| 2001 Q3 | -628.99 Thousand USD | -61.16% |
| 2001 Q2 | -390.27 Thousand USD | -12.7% |
| 2001 FY | -1.63 Million USD | -8.51% |
| 2001 Q1 | -346.28 Thousand USD | 1.93% |
| 2001 Q4 | -277.79 Thousand USD | 55.83% |
| 2000 Q3 | -484.88 Thousand USD | -22.73% |
| 2000 Q4 | -353.09 Thousand USD | 27.18% |
| 2000 Q2 | -395.1 Thousand USD | -42.86% |
| 2000 Q1 | -276.56 Thousand USD | 0.0% |
| 2000 FY | -1.5 Million USD | 17.92% |
| 1999 FY | -1.83 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Allied Energy Corporation | -314.1 Thousand USD | -240.604% |
| Earth Alive Clean Technologies Inc. | -4.6 Million USD | 76.79% |
| Lotus Bio-Technology Development Corp. | - USD | Infinity% |
| MagIndustries Corp. | -28.77 Million USD | 96.282% |
| Itafos Inc. | 24.56 Million USD | 104.355% |
| Potash America, Inc. | -317.37 Thousand USD | -237.097% |
| Yara International ASA | 415 Million USD | 100.258% |
| Yara International ASA | 430.66 Million USD | 100.248% |